In a groundbreaking advancement bridging artificial intelligence and personalized oncology, researchers from the Yong Loo Lin School of Medicine at...

Breast cancer remains one of the most challenging diseases in oncology, in part due to its capacity for late recurrence....

Hepatocellular carcinoma (HCC) remains one of the most formidable challenges in oncology, notably within Egypt—the nation where it is the...

In recent years, Traditional Chinese Medicine (TCM) has continued to play a pivotal role in the treatment landscape for cancer...

In recent years, the adolescent and young adult (AYA) cancer survivor population has gained increasing attention within oncological research, particularly...

Artificial intelligence is rapidly redefining the landscape of medical diagnostics, promising unprecedented capabilities in interpreting complex imaging data. A groundbreaking...

In a groundbreaking study spearheaded by researchers at the University of Virginia Cancer Center, significant strides have been made in...

In a groundbreaking advancement for prostate cancer diagnosis, researchers have developed an innovative ultrasound molecular imaging technique aimed explicitly at...

Long non-coding RNAs (lncRNAs) are emerging as pivotal regulators within the tumor microenvironment (TME), reshaping our understanding of cancer biology...

In a groundbreaking effort to redefine treatment paradigms for oligometastatic prostate cancer (OMPC), researchers have launched a multicenter, randomized controlled...